Q3: Broadly in-line headlines; market weakness visible in the project business

– SEB
Inderes reported sales broadly in line with our estimate and the EBITA came in some EUR 0.1m below our estimate. The organic growth was broadly flat during the quarter as the continued healthy performance in the recurring business (number of commissioned research up 8% y/y) was offset by weakening market momentum on the project business side. The company repeated its guidance for the full year, which in our view is reachable, but has no room for weakening performance.
Sisäänkirjautuminen vaadittu
Tämä sisältö on näkyvissä vain sisäänkirjautuneille käyttäjille